Interestingly, the majority (>55%) of such service providers firms are b

Interestingly, the majority (>55%) of such service providers firms are based in Europe, claims Roots

Kevin Doe
Kevin Doe
6 min read

Repurposing of marketed / shelved / pipeline candidates for the treatment of diseases (different from original target indications) has emerged as a viable business strategy. The rising popularity of this approach can further be attributed to various benefits, such as reduced development timelines, decreased investments and relatively higher success rates (considering that the safety profiles of such candidates have already been established).

 

To order this 250+ page report, which features 100+ figures and 140+ tables, please visit this - https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html

 

The USD 1.2 billion (by 2030) financial opportunity within the drug repurposing service providers market has been analyzed across the following segments:

Type of Repurposing Approaches

Disease-centric approach

Target-centric approach

Drug-centric approach

Therapeutic Area

Same Therapeutic Area

Different Therapeutic Area

Type of Drug Molecule

Biologics

Small Molecule

Key Geographical Region

North America

Europe

Asia-Pacific

 

The Drug Repurposing Service Providers Market, 2020-2030 report features the following companies, which we identified to be key players in this domain: 

Auxillis Pharma

ChemBio Discovery Solutions

Excelra

GVK Bio

Iris Pharma

Lantern Pharma

PanXome

Pharmacelera

Physiogenex

Smart Pharma

Socium

SOM Biotech

 

To Request for sample report -  https://www.rootsanalysis.com/reports/drug-repurposing-service-provides/request-sample.html

Table of Contents

 

1. Preface

2. Executive Summary


3. Introduction

4. Market Landscape

5. Role of Non-Profit / Academic Organizations

 

6. Company Profiles 

7. Partnerships 

8. Big Pharma Initiatives 

9. Case Study: Discontinued Drug Development Programs

10. Cost Saving Analysis

11. Market Forecast and Opportunity Analysis

12.  Covid-19 Impact on Drug Repurposing Service Providers Market

 

13. Recent Advancements and Trends in Outsourcing of Drug Repurposing

 

 

 

14. Interview Transcripts

  

15. Appendix 1: List of Potential Drug-Indication Candidates for Drug Repurposing

  

16. Appendix 2: Tabulated Data

  

17. Appendix 3: List of Companies and Organizations

 

 

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html

  

Other Recent Offerings

 

Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (4th Edition), 2021-2030

 

Global T-Cell (CAR-T, TCR, and TIL) Therapies Market (5th Edition), 2020-2030

 

Oncolytic Virus Therapy Market: Pipeline Review, Developer Landscape and Competitive Insights, 2020-2030

 

 

 

About Roots Analysis

 

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

  

Contact Information

 

Roots Analysis Private Limited

 

Gaurav Chaudhary

 

+1 (415) 800 3415

 

[email protected]

 

Facebook - https://www.facebook.com/RootsAnalysis

 

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

 

Twitter - https://twitter.com/RootsAnalysis

 

Discussion (0 comments)

0 comments

No comments yet. Be the first!